
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
TO EVALUATE THE ROLE OF NIMBA PATRA SWARAS ASCHYOTANA IN THE MANAGEMENT OF KAPHAJA ABHISYANDA WSR MUCOPURULENT CONJUNCTIVITIS
Dr. Shabaz Mansoori*
Abstract Kaphaja Abhisyanada is described as Sarvagata Vyadhi affecting all parts of eye. It characterized by kandu, Guruta, Upadeha, Pichchil Srava, Soph etc. Based of clinical features Kaphaja Abhisyanda can be correlated with Mucopurulant Conjunctivitis. It is type a of bacterial Conjunctivitis and acquired through direct contact with an infected person. It is highly Contagious and common cause of red eye. Kaphaja Abhisyanda (Mucopurulent Conjunctivitis) is a communicable disease; it is a major public concern in the rural areas of developing countries particularly in india. Treatment is needed in this disease to reduce the morbidity, and person to person spread. Objective of the present study was to evaluate the role of Nimba Patra Swaras Ashchyotana in the management of Kaphaja Abhisyanda. 24 patients fulfilling the inclusion criteria of Kaphaja Abhisyanda, were randomly selected O.P.D and I.P.D of Ashwini Ayurvedic Medical Collage Hospital and Research Center, Ring Road, Maralur Tumkur. Ashchyotana was done 2 drops to each eye at the regular interval of 4 hours daily for a period of seven days. Clinical signs and symptoms were given with suitable scores according to their severity and assessed based on relief after treatment. Overall effect of therapies after 7 days of treatment was 55.25% in which it showed marked improvement 8.34%, Moderate 16.67%, Mild 62.25% and no change in 12.5%. Nimba Patra Swaras Ashchyotana has significant effect in the management of Kaphaja Abhisyanda and it is proved to be cost effective, safe and better drug for Ashchyotana in Kaphaja Abhishyanda (Mucopurulent Conjunctivitis). Keywords: Abhishyanda; Nimba Patra swaras; Ashchyotana; Mucopurulent Conjunctivitis. [Full Text Article] [Download Certificate] |
